Brendan Delaney
2021
In 2021, Brendan Delaney earned a total compensation of $5.7M as Chief Operating Officer at Aadi Bioscience.
Compensation breakdown
| Non-Equity Incentive Plan | $81,810 |
|---|---|
| Option Awards | $5,491,827 |
| Salary | $136,615 |
| Total | $5,710,252 |
Delaney received $5.5M in option awards, accounting for 96% of the total pay in 2021.
Delaney also received $81.8K in non-equity incentive plan and $136.6K in salary.
Rankings
In 2021, Brendan Delaney's compensation ranked 2,224th out of 12,415 executives tracked by ExecPay. In other words, Delaney earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,224 out of 12,415 | 82nd |
Division Manufacturing | 870 out of 5,508 | 84th |
Major group Chemicals And Allied Products | 332 out of 2,378 | 86th |
Industry group Drugs | 287 out of 2,099 | 86th |
Industry Pharmaceutical Preparations | 185 out of 1,549 | 88th |
Source: SEC filing on April 26, 2022.
Delaney's colleagues
We found three more compensation records of executives who worked with Brendan Delaney at Aadi Bioscience in 2021.